FONR · As filed with the SEC
Fonar income statement, by fiscal year
The statement as Fonar presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF OPERATIONS · USD, except per-share amounts
| USD, except per-share amounts | FY2025 Year ended Jun 30, 2025 | FY2024 Year ended Jun 30, 2024 | FY2023 Year ended Jun 30, 2023 | FY2022 Year ended Jun 30, 2022 |
|---|---|---|---|---|
| Revenues | ||||
| Patient fee revenue – net of contractual allowances and discounts | 33,179,446 | 33,815,796 | 29,793,993 | 29,582,238 |
| Product sales | 563,296 | 737,727 | 731,607 | 517,939 |
| Service and repair fees | 8,234,053 | 7,452,212 | 7,419,104 | 7,590,865 |
| Service and repair fees – related parties | 180,000 | 139,167 | 110,000 | 110,000 |
| Management and other fees | 49,900,555 | 48,789,287 | 48,640,497 | 48,226,787 |
| Management and other fees – related medical practices | 12,293,968 | 11,949,900 | 11,949,900 | 11,564,316 |
| Total Revenues – Net | 104,351,318 | 102,884,089 | 98,645,101 | 97,592,145 |
| Costs and Expenses | ||||
| Costs related to product sales | 1,018,029 | 1,052,159 | 852,025 | 416,814 |
| Costs related to service and repair fees | 4,508,518 | 3,577,570 | 3,033,967 | 2,991,069 |
| Costs related to service and repair fees – related parties | 323,504 | 144,413 | 44,983 | 43,344 |
| Cost of Revenue | 19,130,935 | 18,199,579 | 16,183,166 | 13,307,819 |
| Costs related to management and other fees | 30,073,045 | 28,626,595 | 26,975,563 | 27,251,268 |
| Costs related to management and other fees – related medical practices | 6,388,281 | 6,143,728 | 5,807,454 | 6,567,887 |
| Research and Development Expense | 1,576,086 | 1,735,949 | 1,567,749 | 1,494,181 |
| Selling, General and Administrative Expense | 29,734,163 | 26,868,732 | 29,390,932 | 23,512,581 |
| Total Costs and Expenses | 92,752,561 | 86,348,725 | 83,855,839 | 75,584,963 |
| Income from Operations | 11,598,757 | 16,535,364 | 14,789,262 | 22,007,182 |
| Interest expense | — | — | (50,131) | (346,552) |
| Interest expense | (25,611) | (76,997) | — | — |
| Interest income – related party | 51,917 | 25,959 | — | — |
| Non-Operating Income (Expense) | 2,118,980 | 2,126,439 | 1,222,176 | 247,158 |
| Other income – related party | 0 | 576,857 | — | — |
| Non-Operating Income (Expense) | 36,195 | 78,763 | (202,720) | 861,087 |
| Income before Provision for Income Taxes and Noncontrolling Interests | 13,780,238 | 19,266,385 | 15,758,587 | 22,768,875 |
| Provision for Income Taxes | (3,106,805) | (5,168,968) | (3,632,071) | (5,534,487) |
| Net Income | — | 14,097,417 | 12,126,516 | 17,234,388 |
| Consolidated Net Income | 10,673,433 | — | — | — |
| Net Income – Noncontrolling Interests | (2,339,172) | (3,530,021) | (2,750,740) | (4,793,482) |
| Net Income – Attributable to FONAR | 8,334,261 | 10,567,396 | 9,375,776 | 12,440,906 |
| Class A Non Voting Preferred | — | — | — | 559,072 |
| Net Income to Common Shareholders | — | — | — | 11,690,796 |
| Common Stockholders | 7,802,351 | 9,908,920 | — | — |
| Class A Non Voting Preferred Stockholders | 396,443 | 490,776 | — | — |
| Common Class C | 135,467 | 167,700 | — | 191,038 |
| Earnings Per Share (Basic) | — | — | — | 1.78 |
| Diluted Net Income Per Common Share Available to Common Stockholders | — | — | — | 1.75 |
| Common Class C | — | — | — | 0.50 |
| Common Stockholders | 1.26 | 1.56 | — | — |
| Common Class C | 0.35 | 0.44 | — | — |
| Common Stockholders | 1.23 | 1.53 | — | — |
| Common Class C | 0.35 | 0.44 | — | — |
| Weighted Average Shares Outstanding | — | — | — | 6,554,209 |
| Common Stockholders | 6,210,852 | 6,350,862 | — | — |
| Common Class C | 382,513 | 382,513 | — | — |
| Weighted Average Shares Outstanding, Diluted | — | — | — | 6,681,713 |
| Common Class C | — | — | — | 382,513 |
| Common Stockholders | 6,338,356 | 6,478,366 | — | — |
| Common Class C | 382,513 | 382,513 | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.